Dear Valued Customers, Suppliers and Partners,
As COVID-19 continues to impact people, businesses, research and routines all over the world, we want to share with you what Brooks is doing to ensure the safety of our employees and partners around the globe while maintaining business continuity in support of our customers.
As of today, all Brooks facilities remain operational as we are deemed an "Essential Business" by the U.S. Department of Homeland Security to support the life science and semiconductor manufacturing industries. As we expect all of our businesses have experienced minor disruptions due to re-alignment of our workforce around stay-at-home orders and social distancing practices but Brooks remains operational and confident in continuing to provide the highest level of quality in our products and services to ensure your success through this crisis.
All Brooks locations have implemented technology and bandwidth enhancements to enable virtual meetings to maintain seamless communications with customers and partners. All locations remain operational, with much of our employee base operating from their homes. The majority of Brooks employees in North America and Europe are working remotely as they continue to execute their daily responsibilities. In Asia, our China based employees are mostly able to work from their respective facilities while Korea, Singapore, and Japan based employees are utilizing "work-from-home", where feasible. In each of our locations, we have employees working on-site due to the nature of their work. We are pleased to report that where roles are necessarily required to be present on-site, the large majority of our colleagues are able to do so and are following guidelines and extensive measures to minimize potential exposures to the virus.
Specifically, with respect to our Life Sciences - Products and Services businesses, all locations including laboratories are operational and we are working closely with our suppliers and carriers to ensure continuity of service. GENEWIZ is taking orders for all service lines and is fast-tracking all orders that are in support of research and development around the COVID-19 virus. We understand the value of your research and we are confident that we have the resources in place to ensure the integrity of your samples stored in our facilities. For more information, please visit www.brookslifesciences.com and
www.genewiz.com for more detailed information.
I would like to reassure you we have a global business continuity plan in place, which has been effective, and we are evaluating the situation on a daily basis, keeping abreast of the guidance from the CDC and WHO, as well as local authorities. As necessary, we will adjust our plans accordingly but always with employee safety as our first priority. We will keep you appropriately informed as to changes in our operations at all Brooks sites.
To all of our customers, partners, and employees - many of whom we see working day and night - I want to thank you for your continued focus to manage through this challenging time. The Brooks team is here to support you.
President and CEO